As curiosity in Latin America’s medical marijuana business grows, a serious inventory exchange in Canada might quickly see the first listings from companies with their core operations in Colombia.
Khiron Life Sciences CEO Alvaro F. Torres informed Marijuana Business Daily the corporate expects to finish the regulatory paperwork in time to start out buying and selling as early as subsequent week on the TSX Venture Exchange underneath the ticker image KHRN.
“This is a major milestone for us and the country, because this means the (TSX Venture Exchange) has also validated the Colombian regulatory system and found it satisfactory,” Torres stated. “I know we are breaking ground for many more companies to list and this is a proud achievement.”
Khiron is amongst a lot of Latin American medical marijuana companies with their core enterprise in Colombia and head workplace in Toronto to faucet Canada’s cannabis-friendly capital markets.
Another, PharmaCielo, is within the midst of a reverse takeover with AAJ Capital 1 Corp. that would result in a inventory exchange itemizing in Toronto within the subsequent few months.
PharmaCielo is the market chief in Colombia based mostly on lively and absolutely operational amenities.
The firm started cultivation at its 1.2 million sq. foot “open air” greenhouse on the finish of 2017.
Colombia is the second-largest federally regulated medical marijuana market on the planet – behind Germany – by inhabitants.
Industry executives plan to make use of Colombia as a springboard to serve the area’s 400 million-plus individuals who stay in nations the place some type of marijuana is authorized.
Matt Lamers may be reached at [email protected]
To join our weekly Canada marijuana enterprise publication, click on right here.